Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research

<p>Key concepts, examples, and potential solutions for misuses and pitfalls of <i>P</i> values.</p>

Saved in:

书目详细资料
主要作者:	Ming Wang (8809334) (author)
其他作者:	Qi Long (22677196) (author)
出版:	2025
主题:	Cancer Methods and Technology Epidemiology Biostatistics Computational Methods Methodology and Modeling
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
由: Jeffrey D. Mandell (14963909)
出版: (2025)

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
由: Nina Rao (15321199)
出版: (2025)

Supplemental Fig. 1 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
由: Noura J. Choudhury (15029759)
出版: (2025)

Supplemental Fig. 2 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
由: Noura J. Choudhury (15029759)
出版: (2025)

Supplemental Fig. 3 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
由: Noura J. Choudhury (15029759)
出版: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
由: Hanyun Zhang (15386757)
出版: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
由: Hanyun Zhang (15386757)
出版: (2025)

Performance advantage of leading researchers compared to non-leading researchers (Mean values for leading researchers).
由: Gerhard Reichmann (17972544)
出版: (2025)

Your PDF contains <b>multiple lecture PPTs</b> from the GIAN course on <i>Migration, Gender, Labour, and International Standards</i>. The content spans historical, sociological, legal, and policy-oriented dimensions of migration.
由: Ganesh Satarkar (22667600)
出版: (2025)

Supplementary Figure S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S2 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S3 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S4 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S5 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S6 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S7 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
由: Alessio Cortellini (11023993)
出版: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
由: Achal Patel (5853731)
出版: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
由: Shuwei Li (16437116)
出版: (2025)

Supplementary Table 19 from Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms
由: Pascal Belleau (14960153)
出版: (2025)

Research attributes of leading vs. non-leading researchers: aggregate ranking (Category 2).
由: Gerhard Reichmann (17972544)
出版: (2025)

The standard curves by the methods of SDM (<i>P </i> = 0.0036) and SSDM (<i>P</i> < 0.001).
由: Fei Chen (13690)
出版: (2025)

Leading researchers: aggregate ranking 2 (Category 2).
由: Gerhard Reichmann (17972544)
出版: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
由: Sami Belhadj (15052341)
出版: (2025)

Leading researchers: aggregate ranking 1 (Categories 1 and 2).
由: Gerhard Reichmann (17972544)
出版: (2025)

Leading researchers: individual rankings V1-V10.
由: Gerhard Reichmann (17972544)
出版: (2025)

Cultivation of <i>Spirulina</i>(<i>Limnospira platensis</i>) using low cost media and its potential to address challenges posed by climate change in the semiarid regions of Southern Africa
由: Keletso Masisi (22675358)
出版: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
由: Erwei Zeng (14958443)
出版: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
由: Erwei Zeng (14958443)
出版: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
由: Erwei Zeng (14958443)
出版: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
由: Erwei Zeng (14958443)
出版: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
由: Erwei Zeng (14958443)
出版: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
由: Josephine K. Dermawan (17079555)
出版: (2025)

The Items addressed in proposed strategies by the teams categorized in the PEN-3 domains.
由: Maria A. Afadapa (22683548)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_g8opuq49k1rssl3jes30f91rgf